Results 131 to 140 of about 6,478 (160)

Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses

Antiviral Research, 2023
Qiuwei Pan, Li Pengfei, Jiajing Li
exaly  

Nirmatrelvir/Ritonavir/Tacrolimus

Reactions Weekly
  +6 more sources

Methylprednisolone/nirmatrelvir+ritonavir

Reactions Weekly, 2022
openaire   +1 more source

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Journal of Pharmaceutical Analysis, 2023
Wujun Chen, Dongming Xing, Xiaolin Wu
exaly  

Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).

Clinical Infectious Diseases, 2023
Rockib Uddin, Jonathan Z Li, Jacob Lemieux   +2 more
exaly  

Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs.

Clinical Infectious Diseases, 2023
Louis Saravolatz
exaly  

Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study

Vaccines, 2022
Riccardo Scotto, Giuseppe Castaldo, Antonio Riccardo Buonomo   +2 more
exaly  

Synthesis of Nirmatrelvir: Development of an Efficient, Scalable Process to Generate the Western Fragment

Organic Process Research and Development, 2023
Javier Magano, Kaitlyn Gray, Russell F Algera   +2 more
exaly  

Real-world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized patients with COVID-19: A retrospective cohort study

Journal of Medical Virology, 2023
Pinhua Pan, Furong Zeng, Li-Ping Jin
exaly  

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source